Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-23-020038

President & CEO sold 12,500 shares at $32.60 ($407,500)

  • President & CEO acquired 12,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Blum Robert I President & CEO 2023-07-03 Option exercise 10b5-1 +12,500 $9.65 $120,625 453,917 D: show line 1 in the form
Blum Robert I President & CEO 2023-07-03 Sale 10b5-1 −12,500 $32.60 $407,500 441,417 D: show line 2 in the form
Open-market sales · 12,500 sh · avg $32.60 · $407,500

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Blum Robert I President & CEO 2023-07-03 Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 −12,500 33,191 D: show line 3 in the form
Loading xslF345X04/form4.xml…